Single-Dose Radiation Therapy for Lung Cancer
Author Information
Author(s): Fritz Peter, Kraus Hans-Jörg, Mühlnickel Werner, Hammer Udo, Dölken Wolfram, Engel-Riedel Walburga, Chemaissani Assad, Stoelben Erich
Primary Institution: St. Marien-Krankenhaus, Department of Radiotherapy
Hypothesis
Is single-dose stereotactic irradiation an effective treatment for stage I non-small cell lung cancer and lung metastases?
Conclusion
Single-dose irradiation is an effective and safe treatment for lung tumors and may serve as a non-invasive alternative to surgery.
Supporting Evidence
- Local control was achieved in 94% of NSCLC cases and 87% of metastases.
- The median survival for patients with lung metastases was 26 months.
- No serious symptomatic side effects were observed in patients.
Takeaway
Doctors used a special type of radiation treatment on patients with lung cancer and found it worked well without causing serious side effects.
Methodology
Patients underwent single-dose stereotactic body radiation therapy with a prescribed dose of 30 Gy.
Limitations
The study had a relatively small sample size and a short follow-up period for some patients.
Participant Demographics
The median age was 65 years for lung metastases and 72 years for NSCLC, with 40 men and 18 women treated.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website